We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Aspirin Prevents Diseases by Controlling Nucleolar Stress

By LabMedica International staff writers
Posted on 13 Jun 2018
Print article
Image: A ball-and-stick model of the aspirin molecule, as found in the solid state (Photo courtesy of Wikimedia Commons).
Image: A ball-and-stick model of the aspirin molecule, as found in the solid state (Photo courtesy of Wikimedia Commons).
By identifying the molecular factors controlling nucleolar stress, researchers were able to outline the mechanism by which aspirin affects this stress and protects against certain disease states including colon cancer.

The nucleolus, the site of ribosome biogenesis, is the largest structure in the nucleus of eukaryotic cells. Nucleoli participate in the formation of signal recognition particles and play a role in the cell's response to stress. Nucleoli comprise proteins, DNA, and RNA and form around specific chromosomal regions called nucleolar organizing regions. Malfunction of nucleoli can be the cause of several human conditions called nucleolopathies, and the nucleolus is being investigated as a target for cancer chemotherapy.

The tumor suppressor gene p53 is well known as an effector of nucleolar stress, but p53 independent mechanisms are largely unknown. Like p53, the NF-kappaB transcription factor plays a critical role in maintaining cellular homeostasis under stress. Many stresses that stimulate NF-kappaB also disrupt nucleoli. However, the link between nucleolar function and activation of the NF-κB pathway is as yet unknown.

Towards a better understanding of nucleolar stress, investigators at the University of Edinburgh (United Kingdom) studied this phenomenon in cell cultures and tumor biopsy specimens removed from colon cancer patients.

They reported in the June 5, 2018, online edition of the journal Nucleic Acids Research that artificial disruption of the PolI (DNA polymerase iota) complex stimulated NF-kappaB signaling. Unlike p53 nucleolar stress response, this effect did not appear to be linked to inhibition of rDNA (ribosomal DNA) transcription. Specific stress stimuli of NF-kappaB induced degradation of a critical component of the PolI complex, TIF-IA. This degradation preceded activation of NF-kappaB and was associated with increased nucleolar size.

Blocking TIF-IA degradation with aspirin blocked stress effects on nucleolar size and NF-kappaB signaling. This was demonstrated by showing a strong correlation between degradation of TIF-IA and activation of NF-kappaB in colorectal tumor biopsy cultures exposed to aspirin.

Senior author Dr. Lesley Stark, senior lecturer on the cancer research center at the University of Edinburgh, said, "We are really excited by these findings as they suggest a mechanism by which aspirin may act to prevent multiple diseases. A better understanding of how aspirin blocks TIF-IA and nucleolar activity provides great promise for the development of new treatments and targeted therapy."

Related Links:
University of Edinburgh

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.